Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to evaluate the efficacy of sitaxsentan (100 mg once daily) plus sildenafil (20 mg TID) as compared to sitaxsentan monotherapy by determining time to clinical worsening in the treatment of subjects with PAH who have completed study B1321001.
Critère d'inclusion
- pulmonary arterial hypertension